πŸ‡ΊπŸ‡Έ FDA
Patent

US 11129805

Dual ACE C-domain/NEP inhibitors

granted A61KA61K31/198A61K31/4035

Quick answer

US patent 11129805 (Dual ACE C-domain/NEP inhibitors) held by ANGIODESIGN (UK) LIMITED expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ANGIODESIGN (UK) LIMITED
Grant date
Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/198, A61K31/4035, A61K38/05, A61K38/06